Published in Cancer Immunol Immunother on June 01, 1995
The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells. Br J Cancer (2000) 1.33
Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis. J Exp Clin Cancer Res (2009) 0.90
Targeting T cells with bispecific antibodies for cancer therapy. BioDrugs (2011) 0.85
CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitro. Br J Cancer (2000) 0.80
Cytotoxicity of cytokine-induced killer cells targeted by a bispecific antibody to gastric cancer cells. Oncol Lett (2013) 0.77
The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect (2010) 5.94
Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med (2001) 4.28
Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science (1998) 4.24
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med (1996) 4.10
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med (1987) 3.82
Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry (1992) 3.48
Applications of retrovirus-mediated expression cloning. Exp Hematol (1996) 3.40
Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology (2002) 3.21
Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun (1970) 3.01
The limitation of referral level fetal ultrasound examination in the detection of spina bifida in Western Australia, 1990-1991. Med J Aust (1993) 3.00
Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab (2001) 2.79
Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol (1996) 2.69
FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet (1998) 2.56
Signal transduction by the B cell antigen receptor and its coreceptors. Annu Rev Immunol (1994) 2.52
Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet (1988) 2.51
Analysis of factors regulating erythrocyte deformability. J Clin Invest (1980) 2.29
Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates. Proc Natl Acad Sci U S A (1987) 2.27
Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA (2000) 2.26
Overlapping functions of the yeast oxysterol-binding protein homologues. Genetics (2001) 2.16
Comparison of community based service with hospital based service for people with acute, severe psychiatric illness. BMJ (1993) 2.14
Work characteristics and pesticide exposures among migrant agricultural families: a community-based research approach. Environ Health Perspect (2001) 2.14
Acid- and base-induced proteins during aerobic and anaerobic growth of Escherichia coli revealed by two-dimensional gel electrophoresis. J Bacteriol (1999) 2.14
HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol (1990) 2.12
Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol (1987) 1.92
Bovine spongiform encephalopathy. Br Med J (Clin Res Ed) (1988) 1.80
Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol (1998) 1.80
Resistant starch lowers fecal concentrations of ammonia and phenols in humans. Am J Clin Nutr (1996) 1.78
c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol (1996) 1.75
Psychiatric and otologic diagnoses in patients complaining of dizziness. Arch Intern Med (1993) 1.75
Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab (1997) 1.73
[Women and part-time employment in the medical profession]. Ned Tijdschr Geneeskd (1999) 1.71
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. Allergy (2008) 1.66
Osmotic gradient ektacytometry: comprehensive characterization of red cell volume and surface maintenance. Blood (1983) 1.64
Acute cholecystitis--room for improvement? Ann R Coll Surg Engl (2002) 1.61
Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities. Eur J Immunol (1999) 1.56
Topographical disorientation following unilateral temporal lobe lesions in humans. Neuropsychologia (1996) 1.55
Comprehensive evaluation of isoprenoid biosynthesis regulation in Saccharomyces cerevisiae utilizing the Genome Reporter Matrix. J Lipid Res (1999) 1.54
The development of haematological changes in homozygous sickle cell disease: a cohort study from birth to 6 years. Br J Haematol (1981) 1.54
Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.53
A novel missense mutation in the factor VIII gene identified by analysis of amplified hemophilia DNA sequences. Nucleic Acids Res (1987) 1.50
Induction of apoptosis by La Crosse virus infection and role of neuronal differentiation and human bcl-2 expression in its prevention. J Virol (1996) 1.50
A technique to detect reduced mechanical stability of red cell membranes: relevance to elliptocytic disorders. Blood (1982) 1.49
In utero lysis of amniotic bands. Ultrasound Obstet Gynecol (1997) 1.47
Duffy phenotype does not influence the clinical severity of sickle cell disease. Clin Immunol (2000) 1.46
Monovalent cation composition and ATP and lipid content of irreversibly sickled cells. Blood (1978) 1.45
A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid. Lab Anim Sci (1990) 1.44
T-cell receptor V beta-family usage in primary cutaneous and primary nodal T-cell non-Hodgkin's lymphomas. J Invest Dermatol (1992) 1.43
Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype. Blood Cells Mol Dis (2010) 1.43
Expression of spleen cell immunoglobulin phenotype in hybrids with myeloma cell lines. Somatic Cell Genet (1981) 1.42
Stage is a better prognostic indicator than morphologic subtype in primary noncutaneous T-cell lymphoma. Am J Clin Pathol (1990) 1.41
Caring for patients with enterocutaneous fistulae. Br J Nurs (1992) 1.40
PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity (1999) 1.40
Comparison of tetracaine-adrenaline-cocaine (TAC) with topical lidocaine-epinephrine (TLE): efficacy and cost. Am J Emerg Med (1995) 1.40
Method of preparing emergency medicine residents for giving legal depositions. J Am Osteopath Assoc (1999) 1.39
The burden of motorcycle-related neuro-trauma in Ireland and associated helmet usage. Br J Neurosurg (2009) 1.39
Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett (1998) 1.36
Deformability of oxygenated irreversibly sickled cells. J Clin Invest (1980) 1.36
Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol (1999) 1.35
Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia (1999) 1.34
Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J Exp Med (1997) 1.33
Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med (1990) 1.32
Human hybridomas from malignant gliomas. Lancet (1982) 1.27
Sickle cell disease; a general overview. Neth J Med (2004) 1.26
Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. J Immunol (1998) 1.26
The Oregon migrant farmworker community: an evolving model for participatory research. Environ Health Perspect (2001) 1.26
Patients' aims for epilepsy surgery: desires beyond seizure freedom. Epilepsia (2001) 1.25
Microdysgenesis in resected temporal neocortex: incidence and clinical significance in focal epilepsy. Neurology (1988) 1.25
Lithium toxicity with rarely reported ECG manifestations. Ann Emerg Med (1982) 1.25
A twelve-year review of central nervous system bacterial abscesses; presentation and aetiology. Clin Microbiol Infect (2003) 1.24
Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol (1998) 1.24
Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression. Mol Carcinog (1988) 1.24
Studies of prototype live hepatitis A virus vaccines in primate models. J Infect Dis (1988) 1.23
Purification and kinetic characterization of a monovalent cation-activated glycerol dehydrogenase from Aerobacter aerogenes. J Biol Chem (1974) 1.22
Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J Clin Invest (1989) 1.22
Tolerance to rat monoclonal antibodies. Implications for serotherapy. J Exp Med (1986) 1.21
Evaluation of a Treponema pallidum western immunoblot assay as a confirmatory test for syphilis. J Clin Microbiol (1992) 1.20
Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.20
Neutrophil activation in sickle cell disease. J Leukoc Biol (1999) 1.19
Pain coping strategies predict perceived control over pain. Pain (1998) 1.17
Privacy in genetics research. Science (1999) 1.17
Management of acute cholecystitis in UK hospitals: time for a change. Postgrad Med J (2004) 1.17
Predictors of health status and life satisfaction in spinal cord injury. Arch Phys Med Rehabil (1998) 1.17
Neuroendocrine disorders after traumatic brain injury. J Neurol Neurosurg Psychiatry (2008) 1.16
Application of Illumina next-generation sequencing to characterize the bacterial community of the Upper Mississippi River. J Appl Microbiol (2013) 1.15
Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest (1986) 1.15
The neural areas that control the retrieval and selection of semantics. Neuropsychologia (2004) 1.15
In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant (2001) 1.15
Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes. J Clin Invest (1984) 1.14
Current technologies for HER2 testing in breast cancer. Crit Rev Oncol Hematol (2011) 1.14
Baroregulation of vasopressin release in adipsic diabetes insipidus. J Clin Endocrinol Metab (2002) 1.13
Force production characteristics in Parkinson's disease. Exp Brain Res (1989) 1.13
External radiation exposure and mortality in a cohort of uranium processing workers. Am J Epidemiol (2000) 1.13
Solubilization of an antigen associated with certain bronchial tumours. Eur J Cancer (1975) 1.12
The herpes simplex virus type 1 Fc receptor discriminates between IgG1 allotypes. Eur J Immunol (2000) 1.12
Chaotic atrial mechanism. Am Heart J (1969) 1.11
Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum (1990) 1.11
Third-generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy. J Antimicrob Chemother (2005) 1.10